Track Sedana Medical AB (publ) — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Sedana Medical AB (publ) SEDANA.ST Open Sedana Medical AB (publ) in new tab

9.44 SEK
EPS
-0.40
P/B
1.05
ROE
-4.31
Beta
0.80
Loading chart...
Key Metrics
Earnings dateJuly 17, 2026
EPS-0.40
Book Value9.07
Price to Book1.05
Debt/Equity0.84
% Insiders24.686%
Growth
Revenue Growth-0.07%
Estimates
Forward P/E-56.12
Forward EPS-0.17

DCF Valuation

Tweak assumptions to recompute fair value for Sedana Medical AB (publ) (SEDANA.ST)
Currency: SEK
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Sedana Medical AB (publ) Logo Sedana Medical AB (publ) Analysis (SEDANA.ST)

Sweden Health Care Official Website Stock

Is Sedana Medical AB (publ) a good investment? Sedana Medical AB (publ) (SEDANA.ST) is currently trading at 9.44 SEK.

Earnings Schedule: Sedana Medical AB (publ) is expected to release its next earnings report on July 17, 2026. The market consensus estimate for Forward EPS is -0.17.

Investor FAQ

Does Sedana Medical AB (publ) pay a dividend?

No, it does not currently pay a dividend.

What asset class is Sedana Medical AB (publ)?

Sedana Medical AB (publ) is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be July 17, 2026. The company currently has a trailing EPS of -0.40.

Company Profile

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for maintenance of sedation in intubated or tracheostomised mechanically ventilated adult and paediatric patients from 3 years of age; and Sedaconda Filling Adapter, a single-use medical device; FlurAbsorb Pro-L and Pro-S; FlurAbsorb and Mounts; Scavenging Tube, a one piece pre-connected tube, that is designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; and Mindray exhaust connector enables to connect the exhaust of the ventilator to an active or passive scavenging system. The company was founded in 1999 and is headquartered in Danderyd, Sweden.

Exchange Ticker
STO (Sweden) SEDANA.ST

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
May 26, 2021 4.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion